Welcome to the e-CCO Library Archive!
M. Thörn1, A. Rönnblom1, B.-M. Eriksson1, F. Rorsman1, P. Sangfelt1, A. Wanders2, K. Bondeson3, 1Uppsala University, Dept of Medical Sciences, Uppsala, Sweden, 2Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden, 3Uppsala University, Dept of Medical Biochemistry and Microbiology, Uppsala, Sweden
Impact of induction therapy with 3 doses of infliximab on deep remission in paediatric patients with active Crohn's Disease
E. Szymanska*1, M. Dadalski2, S. Szymanska3, W. Grajkowska3, M. Pronicki3, J. Kierkus2
1Children’s Memorial Health Institute, Department of Pediatrics, Nutrition and Metabolic Disorders,, Warsaw, Poland, 2Children’s Memorial Health Institute, Department of Gastroenterology, Hepatology and Feeding Disorders, Warsaw, Poland, 3Children’s Memorial Heath Institute, Department of Pathology, Warsaw, Poland
“IBD MOM”: report of a new concept in the treatment of IBD in pregnancy
A. Shitrit1, S. Granovsky-Grisaru2, T. Adar1, B. Koslowsky1, B. Mazuz1, M. Shenwald1, E. Goldin1, 1Shaare Zedek Medical Center, Digestive diseases institute, Jerusalem, Israel, 2Shaare Zedek Medical Center, Department of obstetrics and gynecology, division of maternal fetal medicine, Jerusalem, Israel
L. Alessandroni1, C. Papi2, L.G. Papparella3, M.C. Addarii1, A. Kohn1, 1San Camillo-Forlanini Hospital, Rome, Italy, 2San Filippo-Neri Hospital, Rome, Italy, 3Campus Bio-Medico, Rome, Italy
Association between Inflammatory Bowel Disease activity and therapeutic drug monitoring of azathioprine and infliximab comparing free and total antidrug antibody measurement
M. Ward*1, 2, B. Warner2, N. Unsworth3, J. Sanderson2, Z. Arkir3, P. Irving2
1Alfred Hospital, Gastroenterology, Melbourne, Australia, 2Guy’s and St. Thomas Hospital, Gastroenterology, London, United Kingdom, 3Guy’s and St. Thomas Hospital, Reference Chemistry, Viapath, London, United Kingdom
Smart phones for inflammatory bowel disease
L. Patience1, A. Watson2, 1Centre of Health Science, Research and Development, Inverness, United Kingdom, 2Raigmore Hospital/Centre of Healt Science, Colorectal Surgery/Research and Development, Inverness, United Kingdom
C. Petruzziello1, A. Armuzzi2, A. Kohn3, R. D'Incà4, C. Papi5, L. Spina6, L. Guidi2, M.L. Scribano3, S. Onali1, G. Condino1, E. Calabrese1, R. Monterubbianesi3, P. Alvisi7, W. Fries8, G. Riegler9, F. Castiglione10, G. Margagnoni5, G. Meucci11, F. Rogai12, F. Pallone1, L. Biancone1, 1Università Tor Vergata, Roma, Italy, 2Med Int/GI CIC Università Cattolica, Roma, Italy, 3AO S. Camillo Forlanini, Roma, Italy, 4Università Padova, Padova, Italy, 5UOC GE/Hep, AO S. Filippo Neri, Roma, Italy, 6Università S. Donato, Milano, Milano, Italy, 7Ospedale Maggiore, Bologna, Bologna, Italy, 8Università Messina, Messina, Italy, 9SUN Seconda Università di Napoli, Napoli, Italy, 10Università Federico II, Napoli, Napoli, Italy, 11Ospedale S. Giuseppe, Milano, Milano, Italy, 12AOU Careggi, Firenze, Firenze, Italy
Immunogenicity of 13-valent pneumococcal conjugated vaccine in pediatric patients with inflammatory bowel disease
A. Banaszkiewicz*1, B. Targonska2, K. Kowalska-Duplaga3, K. Karolewska-Bochenek1, A. Sieczkowska4, A. Gawronska1, U. Grzybowska-Chlebowczyk5, E. Krzesiek6, I. Lazowska-Przeorek1, M. Kotowska1, E. Sienkiewicz1, J. Walkowiak2, H. Gregorek7, A. Radzikowski1, P. Albrecht1
1Medical University of Warsaw, Dept. of Pediatric Gastroenterology and Nutrition, Warsaw, Poland, 2Poznan University of Medical Sciences, Dept. of Pediatric Gastroenterology and Metabolic Diseases, Poznan, Poland, 3Jagiellonian University Medical College, Department of Pediatrics, Gastroenterology and Nutrition, Krakow, Poland, 4Medical University of Gdansk, Department of Pediatric Gastroenterology, Hepatology and Nutrition, Gdansk, Poland, 5Medical University of Silesia, Department of Pediatrics, Gastroenterology Unit, Katowice, Poland, 6Wroclaw Medical University, Department of Pediatrics, Gastroenterology and Nutrition, Wroclaw, Poland, 7The Children's Memorial Health Institute, Department of Microbiology and Clinical Immunology, Warsaw, Poland
eHealth: Individualisation of MMX mesalamine treatment and optimization of disease course via a self-managed web-based solution in active ulcerative colitis
N. Pedersen1,2, J. Burisch3, L. Martinsen4, M. Bennedsen5, P. Thielsen6, S. Bell7, Z. Vegh3, A. Haaber8, D. Duricova9, T. Jess10, E. Langholz11, P. Munkholm3, 1Herlev University Hospital, Department of Gastroenterology, Copenhagen, Denmark, 2University, Gastroenterology, Copenhagen, Denmark, 3University of Copenhagen, Gastroenterology, Herlev, Denmark, 4Nykøbing Falster Hospital, Gastroenterology, Nykøbing Falster, Denmark, 5Frederikssund Hospital, Gastroenterology, Frederikssund, Denmark, 6Herlev University Hospital, Gastroenterology, Herlev, Denmark, 7University of Melbourne, Gastroenterology, Melbourne, Australia, 8Gentofte Hospital, Gastroenterology, Gentofte, Denmark, 9Charls University Hospital, IBD research centre ISCARE a.s., Herlev, Denmark, 10State Serum Institute, Epidemiology, Copenhagen, Denmark, 11Gentofte, Gastroenterology, Gentofte, Denmark
I.A. Pintilie, O. Nedelciuc, A.M. Blaj, C. Mihai, C. Cijevschi Prelipcean, .University of Medicine and Pharmacy Gr. T. Popa, Center of Gastroenterology and Hepatology “St. Spiridon” Hospital, Iasi, Romania
The sooner, the better: Early treatment of Crohn's Disease precludes a bad outcome
Y. Gonzalez Lama*, C. Suarez Ferrer, G.P. Irene, M. Calvo Moya, V. Matallana Royo, M.I. Vera Mendoza, L. Abreu Garcia
Hospital Puerta De Hierro, Gastroenterology, Madrid, Spain
Yield of colon surveillance and clinical outcome after faecal diversion in patients with Crohn's disease
D. van den Nieuwendijk1, C.I. Baeten2, J.C. Hardwick1, R.A. Veenendaal1, A.R. Vahrmeijer2, B.A. Bonsing2, A.E. van der Meulen-de Jong1, 1Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, Netherlands, 2Leiden University Medical Center, Surgery, Leiden, Netherlands